Annual ROA
11.86%
+34.92%+151.43%
December 31, 2023
Summary
- As of February 8, 2025, PLX annual return on assets is 11.86%, with the most recent change of +34.92% (+151.43%) on December 31, 2023.
- During the last 3 years, PLX annual ROA has risen by +23.37% (+203.04%).
- PLX annual ROA is now -82.06% below its all-time high of 66.10%, reached on December 31, 2015.
Performance
PLX ROA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROA
-11.58%
+5.05%+30.37%
September 30, 2024
Summary
- As of February 8, 2025, PLX quarterly return on assets is -11.58%, with the most recent change of +5.05% (+30.37%) on September 30, 2024.
- Over the past year, PLX quarterly ROA has dropped by -26.53% (-177.46%).
- PLX quarterly ROA is now -114.89% below its all-time high of 77.78%, reached on December 31, 2015.
Performance
PLX Quarterly ROA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROA Formula
ROA = Net Income
Total Assets ✕ 100%
Total Assets ✕ 100%
PLX ROA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +151.4% | -177.5% |
| 3 y3 years | +203.0% | -177.5% |
| 5 y5 years | +129.9% | -177.5% |
PLX ROA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +130.4% | -177.5% | +63.4% |
| 5 y | 5-year | at high | +130.4% | -177.5% | +65.0% |
| alltime | all time | -82.1% | +103.2% | -114.9% | +98.2% |
Protalix BioTherapeutics ROA History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -11.58%(-30.4%) |
| Jun 2024 | - | -16.63%(-302.6%) |
| Mar 2024 | - | 8.21%(-24.4%) |
| Dec 2023 | 11.86%(-151.4%) | 10.86%(-27.4%) |
| Sep 2023 | - | 14.95%(+10.3%) |
| Jun 2023 | - | 13.56%(-153.0%) |
| Mar 2023 | - | -25.60%(+8.1%) |
| Dec 2022 | -23.06%(-40.8%) | -23.68%(-9.0%) |
| Sep 2022 | - | -26.03%(+11.0%) |
| Jun 2022 | - | -23.44%(-16.1%) |
| Mar 2022 | - | -27.94%(-11.7%) |
| Dec 2021 | -38.96%(+238.5%) | -31.63%(+34.0%) |
| Sep 2021 | - | -23.60%(-3.8%) |
| Jun 2021 | - | -24.54%(+42.8%) |
| Mar 2021 | - | -17.18%(+79.1%) |
| Dec 2020 | -11.51%(-66.5%) | -9.59%(-5.7%) |
| Sep 2020 | - | -10.17%(+9.2%) |
| Jun 2020 | - | -9.31%(-40.5%) |
| Mar 2020 | - | -15.66%(-52.6%) |
| Dec 2019 | -34.31%(-13.5%) | -33.04%(-17.9%) |
| Sep 2019 | - | -40.22%(-7.5%) |
| Jun 2019 | - | -43.47%(+0.4%) |
| Mar 2019 | - | -43.29%(+3.8%) |
| Dec 2018 | -39.68%(-63.3%) | -41.72%(-23.0%) |
| Sep 2018 | - | -54.15%(-17.3%) |
| Jun 2018 | - | -65.49%(+36.6%) |
| Mar 2018 | - | -47.93%(-60.2%) |
| Dec 2017 | -108.04%(+230.2%) | -120.45%(+14.1%) |
| Sep 2017 | - | -105.56%(+11.5%) |
| Jun 2017 | - | -94.65%(-7.4%) |
| Mar 2017 | - | -102.26%(+189.9%) |
| Dec 2016 | -32.72%(-149.5%) | -35.28%(-160.1%) |
| Sep 2016 | - | 58.67%(-8.1%) |
| Jun 2016 | - | 63.81%(-12.0%) |
| Mar 2016 | - | 72.52%(-6.8%) |
| Dec 2015 | 66.10%(-311.6%) | 77.78%(-340.4%) |
| Sep 2015 | - | -32.35%(-6.5%) |
| Jun 2015 | - | -34.59%(+5.4%) |
| Mar 2015 | - | -32.82%(+4.5%) |
| Dec 2014 | -31.24%(+7.9%) | -31.42%(+0.9%) |
| Sep 2014 | - | -31.15%(+2.8%) |
| Jun 2014 | - | -30.29%(-7.6%) |
| Mar 2014 | - | -32.77%(+5.1%) |
| Dec 2013 | -28.94%(+62.6%) | -31.19%(-4.6%) |
| Sep 2013 | - | -32.70%(-8.1%) |
| Jun 2013 | - | -35.57%(+168.5%) |
| Mar 2013 | - | -13.25%(-17.8%) |
| Dec 2012 | -17.80%(-71.6%) | -16.11%(+3.7%) |
| Sep 2012 | - | -15.54%(-25.4%) |
| Jun 2012 | - | -20.83%(-62.8%) |
| Mar 2012 | - | -55.97%(+1.2%) |
| Dec 2011 | -62.69% | -55.32%(+8.2%) |
| Sep 2011 | - | -51.12%(+26.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2011 | - | -40.53%(+19.1%) |
| Mar 2011 | - | -34.02%(-5.9%) |
| Dec 2010 | -35.49%(-15.6%) | -36.14%(-23.5%) |
| Sep 2010 | - | -47.26%(-16.8%) |
| Jun 2010 | - | -56.82%(+4.2%) |
| Mar 2010 | - | -54.54%(-4.2%) |
| Dec 2009 | -42.07%(+11.6%) | -56.95%(+15.1%) |
| Sep 2009 | - | -49.48%(+7.4%) |
| Jun 2009 | - | -46.08%(+15.0%) |
| Mar 2009 | - | -40.07%(+8.2%) |
| Dec 2008 | -37.69%(-44.1%) | -37.05%(-32.5%) |
| Sep 2008 | - | -54.91%(-4.4%) |
| Jun 2008 | - | -57.45%(-25.3%) |
| Mar 2008 | - | -76.91%(-13.4%) |
| Dec 2007 | -67.46%(+22.9%) | -88.85%(-3.3%) |
| Sep 2007 | - | -91.89%(-13.4%) |
| Jun 2007 | - | -106.11%(-0.7%) |
| Mar 2007 | - | -106.84%(-27.9%) |
| Dec 2006 | -54.89%(-62.8%) | -148.13%(-76.5%) |
| Sep 2006 | - | -629.12%(+19.4%) |
| Jun 2006 | - | -526.80%(+41.2%) |
| Mar 2006 | - | -373.20%(+21.8%) |
| Dec 2005 | -147.50%(-60.4%) | -306.36%(-28.5%) |
| Sep 2005 | - | -428.25%(+4.4%) |
| Jun 2005 | - | -410.06%(+3.6%) |
| Mar 2005 | - | -395.95%(+5.2%) |
| Dec 2004 | -372.39%(+2029.2%) | -376.35%(+1371.3%) |
| Sep 2004 | - | -25.58%(+13.2%) |
| Jun 2004 | - | -22.59%(+28.3%) |
| Mar 2004 | - | -17.61%(+0.5%) |
| Dec 2003 | -17.49%(+10.8%) | -17.53%(+1.9%) |
| Sep 2003 | - | -17.20%(+4.2%) |
| Jun 2003 | - | -16.50%(+2.5%) |
| Mar 2003 | - | -16.10%(+1.7%) |
| Dec 2002 | -15.78%(-29.8%) | -15.83%(+1.2%) |
| Sep 2002 | - | -15.65%(-4.5%) |
| Jun 2002 | - | -16.38%(+4.9%) |
| Mar 2002 | - | -15.61%(-32.7%) |
| Dec 2001 | -22.49%(+321.2%) | -23.19%(+9.6%) |
| Sep 2001 | - | -21.15%(+33.5%) |
| Jun 2001 | - | -15.84%(+27.7%) |
| Mar 2001 | - | -12.40%(+128.4%) |
| Dec 2000 | -5.34%(-81.7%) | -5.43%(-72.3%) |
| Sep 2000 | - | -19.57%(-25.8%) |
| Jun 2000 | - | -26.37%(+14.6%) |
| Mar 2000 | - | -23.01%(-27.8%) |
| Dec 1999 | -29.26%(+21.8%) | -31.87%(+79.3%) |
| Sep 1999 | - | -17.77%(+65.1%) |
| Jun 1999 | - | -10.76%(+22.3%) |
| Mar 1999 | - | -8.80% |
| Dec 1998 | -24.03%(-1611.3%) | - |
| Dec 1997 | 1.59%(-11.2%) | - |
| Dec 1996 | 1.79% | - |
FAQ
- What is Protalix BioTherapeutics annual return on assets?
- What is the all time high annual ROA for Protalix BioTherapeutics?
- What is Protalix BioTherapeutics annual ROA year-on-year change?
- What is Protalix BioTherapeutics quarterly return on assets?
- What is the all time high quarterly ROA for Protalix BioTherapeutics?
- What is Protalix BioTherapeutics quarterly ROA year-on-year change?
What is Protalix BioTherapeutics annual return on assets?
The current annual ROA of PLX is 11.86%
What is the all time high annual ROA for Protalix BioTherapeutics?
Protalix BioTherapeutics all-time high annual return on assets is 66.10%
What is Protalix BioTherapeutics annual ROA year-on-year change?
Over the past year, PLX annual return on assets has changed by +34.92% (+151.43%)
What is Protalix BioTherapeutics quarterly return on assets?
The current quarterly ROA of PLX is -11.58%
What is the all time high quarterly ROA for Protalix BioTherapeutics?
Protalix BioTherapeutics all-time high quarterly return on assets is 77.78%
What is Protalix BioTherapeutics quarterly ROA year-on-year change?
Over the past year, PLX quarterly return on assets has changed by -26.53% (-177.46%)